A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells

被引:11
|
作者
Wang, Yubao [1 ,2 ]
Li, Ben B. [1 ,2 ,3 ]
Li, Jing [1 ]
Roberts, Thomas M. [1 ,2 ]
Zhao, Jean J. [1 ,2 ,3 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[3] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
关键词
VULNERABILITIES; EXPRESSION; KRAS; PREDICTOR; INHIBITOR; DISCOVERY; GROWTH; POTENT; SCALE;
D O I
10.1016/j.isci.2018.10.015
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The role of maternal and embryonic leucine zipper kinase (MELK) in cancer cell proliferation has been contentious, with recent studies arriving at disparate conclusions. We investigated the in vitro dependency of cancer cells on MELK under a range of assay conditions. Abrogation of MELK expression has little effect under common culture conditions, in which cells are seeded at high densities and reach confluence in 3-5 days. However, MELK dependency becomes clearly apparent in clonogenic growth assays using either RNAi or CRISPR technologies to modulate MELK expression. This dependency is in sharp contrast to that of essential genes, such as those encoding classic mitotic kinases, but is similar to that of other oncogenes including MYC and KRAS. Our study provides an example demonstrating some of the challenges encountered in cancer target validation, and reveals how subtle, but important, technical variations can ultimately lead to divergent outcomes and conclusions.
引用
收藏
页码:149 / +
页数:20
相关论文
共 50 条
  • [1] MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells
    Li, Gang
    Yang, Mei
    Zuo, Li
    Wang, Mei-Xing
    [J]. ONCOLOGY LETTERS, 2018, 15 (06) : 9934 - 9940
  • [2] Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
    O'Grady, Shane
    Crown, John
    Duffy, Michael J.
    [J]. MEDICAL ONCOLOGY, 2022, 39 (10)
  • [3] Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
    Shane O’Grady
    John Crown
    Michael J. Duffy
    [J]. Medical Oncology, 39
  • [4] Investigation of novel MELK interacting proteins and signaling pathways in triple-negative breast cancer
    McDonald, Ian M.
    Chacin, Raquel C. Martinez
    Wang, Xianxi
    Herring, Laura E.
    Emanuele, Michael J.
    Graves, Lee M.
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2017, 16 (08) : S48 - S48
  • [5] Lysophosphatidic acid-induced proliferation of cancer stem cells in triple-negative breast cancer
    Hirata, Naoya
    Sekino, Yuko
    Kanda, Yasunari
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S183 - S183
  • [6] Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells
    Chepikova, Olga E.
    Malin, Dmitry
    Strekalova, Elena
    Lukasheva, Elena V.
    Zamyatnin, Andrey A., Jr.
    Cryns, Vincent L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (03) : 549 - 564
  • [7] Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells
    Olga E. Chepikova
    Dmitry Malin
    Elena Strekalova
    Elena V. Lukasheva
    Andrey A. Zamyatnin
    Vincent L. Cryns
    [J]. Breast Cancer Research and Treatment, 2020, 183 : 549 - 564
  • [8] Calsequestrin 2 regulates proliferation, migration, and invasion in triple-negative breast cancer cells
    Kim, Ju Hee
    Hong, Bok Sil
    Heo, Woohang
    Han, Jong Min
    Han, Wonsik
    Noh, Dong-Young
    Moon, Hyeong-Gon
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [9] The expression of MELK, a growth regulator of triple-negative breast cancer, is regulated by p53
    Bollu, Lakshmi Reddy
    Brown, Powel H.
    Mazumdar, Abhijit
    Zhao, Dekuang
    Ma, Yanxia
    [J]. CANCER RESEARCH, 2017, 77
  • [10] Triple-Negative Breast Cancer
    Quyen D. Chu
    King, Tari
    Hurd, Thelma
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012